Related references
Note: Only part of the references are listed.
Article
Oncology
Jee Won Park et al.
Summary: Autophagy flux differs between luminal and triple-negative breast cancers. miR-181a regulates autophagy-related proteins ATG5 and ATG2B, which are associated with cancer stemness in TNBC. Curcumin promotes autophagy flux and attenuates cancer stemness in TNBC.
MOLECULAR ONCOLOGY
(2022)
Article
Pharmacology & Pharmacy
Yao Xiao et al.
Summary: This study investigated the anti-tumor effect of icaritin-loaded PLGA nanoparticles on gastric cancer cells. The results showed that PLGA@Icaritin NPs could efficiently enter GC cells and significantly suppress cell growth, induce LDH leakage, arrest cells at G2 phase, and inhibit invasion and metastasis. Furthermore, PLGA@Icaritin NPs could activate anti-tumor immunity and recruit immune cells. The study highlights the potential of PLGA@Icaritin NPs as a therapeutic strategy for gastric cancer.
Review
Cell Biology
Taritsa Iulianna et al.
Summary: Recently, the potential role of lysosomes in anticancer therapies has gained attention in the field of immuno-oncology. Targeting lysosomes triggers apoptotic pathways, inhibits cytoprotective autophagy, and activates immunogenic cell death (ICD). ICD stimulates immune response against dead-cell antigens. Stressors like ROS can induce lysosome membrane permeability (LMP) leading to ICD. Dying cells express markers that activate immune cells, and dendritic cells present neoantigens from dying cells to T cells. The discovery of ICD-inducing agents is significant due to the potential for triggering autoimmunity. In this review, mechanisms of activating lysosome-induced cell death in cancer cells and strategies for promoting LMP in tumors are discussed.
CELL DEATH & DISEASE
(2022)
Review
Cell Biology
Tatiana Mishchenko et al.
Summary: This article discusses the non-conventional cell death mechanisms triggered by PDT, emphasizing the role and contribution of immunogenic cell death (ICD) in these pathways. The authors also discuss the obstacles and propose areas of research to overcome these challenges and develop highly effective anti-cancer therapy based on PDT.
CELL DEATH & DISEASE
(2022)
Review
Chemistry, Multidisciplinary
Zhilin Li et al.
Summary: This article reviews the use of nanostructure-based drug delivery systems (NDDSs) to enhance the effectiveness of tumor immunotherapy. By inducing immunogenic cell death (ICD) and releasing danger-associated molecular patterns (DAMPs) and tumor-associated antigens, in combination with chemotherapy, photodynamic therapy, photothermal therapy, and radiotherapy, the tumor immunosuppressive microenvironment can be improved, resulting in increased sensitivity to immunotherapy and reduced side effects.
Article
Biochemistry & Molecular Biology
Serge Yannick Ouedraogo et al.
Summary: BRCA1 and BRCA2 are the most commonly mutated tumor suppressor genes associated with hereditary breast cancer. Mutations in TP53, PIK3CA, PTEN and AKT1 also have high frequency in breast cancer. Mutation carriers are more common in Her2 negative patients and patients who underwent surgery and chemotherapy. The mutation spectrum of these genes is still unknown in most Sub-Saharan African population.
MOLECULAR GENETICS AND GENOMICS
(2022)
Article
Medical Laboratory Technology
Yanjun Hou et al.
Summary: Breast cancer is a heterogeneous group of cancer at both histological and molecular levels, with ER, PR, and HER2 commonly used as biomarkers for treatment planning. Recent advances in immunotherapy have highlighted the importance of PD-L1 testing. As understanding of breast cancer molecular characteristics increases, more biomarkers are needed for personalized treatments.
SEMINARS IN DIAGNOSTIC PATHOLOGY
(2022)
Article
Oncology
Hui Luo et al.
Summary: This study found that targeting SCD1 can increase the sensitivity of esophageal squamous cell carcinoma (ESCC) to radiation therapy and induce ferroptosis and immunogenic cell death (ICD). Inhibition of SCD1 can improve radiation resistance in ESCC cells and has potential clinical applications.
Article
Chemistry, Multidisciplinary
Zhiren Wang et al.
Summary: Camptothesome is an innovative nanovesicle therapeutic that has shown promising results in the treatment of colorectal cancer. It is taken up by cancer cells through a specific pathway and induces immunogenic cancer cell death. The use of Camptothesome-treated tumor cells as a vaccine has proven effective in preventing tumor growth. Furthermore, Camptothesome demonstrates superior anti-cancer efficacy and immune response compared to other treatments. It also enhances the effectiveness of immune checkpoint inhibitors in shrinking late-stage CRC tumors and prolonging survival.
JOURNAL OF CONTROLLED RELEASE
(2022)
Article
Immunology
Jie Ren et al.
Summary: Increasing evidence suggests that immunogenic cell death (ICD) plays critical functions in many tumors. This study investigates the therapeutic possibilities and mechanism of utilizing ICD in melanoma. Through pan-cancer analysis and clustering, melanoma samples were separated into two subtypes with different prognosis and immune microenvironment based on ICD expression traits. An ICD-dependent risk signature (ICDRS) was determined using LASSO-Cox regression analysis. ICDRS showed accurate prognosis evaluation and could be used for patient classification in melanoma treatment.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Oncology
Yoon Ah Cho et al.
Summary: This study investigates the prognostic relevance of the PIK3CA mutation along with PD-L1, c-Met, and mismatch repair deficiency (dMMR) in Asian women with breast cancer. The results suggest that the PIK3CA mutation, along with c-Met positivity or dMMR/MSI status, may be associated with poor prognosis in breast cancer, especially in Asian women.
Article
Biotechnology & Applied Microbiology
Lisa Dressler et al.
Summary: This study compiled a literature-based repertoire of 3355 well-known or predicted drivers of cancer and non-cancer somatic evolution in 122 cancer types and 12 non-cancer tissues. The analysis of these genes revealed that the known compendium of drivers is still incomplete and biased towards frequently occurring coding mutations. There is a high overlap between drivers of cancer and non-cancer somatic evolution, although significant differences exist in their recurrence. Additionally, a set of evolutionarily conserved and essential genes were identified, and alteration in even one of these genes is sufficient to drive clonal expansion but not malignant transformation.
Review
Oncology
Constantin N. Baxevanis et al.
Summary: Cancer evolution is a complex process influenced by genetic factors and external stimuli that trigger signaling pathways between tumor cells and the immune system. The immune system plays a dual role in cancer progression, conveying protective antitumor immunity while also facilitating tumor development by shaping tumor immunogenicity. Understanding the interaction between immune elements and tumor cells within the tumor microenvironment is crucial for prognosis and developing immunotherapy strategies for various cancers.
SEMINARS IN CANCER BIOLOGY
(2021)
Review
Cell Biology
Clementina Sansone et al.
Summary: Immunogenic cell death (ICD) plays a crucial role in stimulating immune responses by releasing DAMPs and triggering an immune reaction. ICD can develop and promote immune cell responses, enhancing the effectiveness of anticancer immune responses.
Article
Oncology
Alejandra Reyes-Ruiz et al.
Summary: ICRP induces immunogenic cell death in breast cancer cells, leading to long-term antitumor memory.
BRITISH JOURNAL OF CANCER
(2021)
Article
Genetics & Heredity
Shaojun Hu et al.
Summary: The study classified TNBC into immune subtypes and discovered significant differences in prognosis, gene mutation, immune infiltration, drug sensitivity, and heterogeneity among subtypes. The findings validate the independent role of immune subtypes in tumor progression and immunotherapy for TNBC, offering a new perspective for personalized immunotherapy and prognosis evaluation of TNBC patients in the future.
FRONTIERS IN GENETICS
(2021)
Article
Cell Biology
Xiaoxi Li et al.
Summary: Chemotherapeutic agents, including the cardiac glycoside oleandrin, have been shown to induce immunogenic cell death (ICD) in breast cancer cells, enhancing anti-tumor immune responses. Oleandrin treatment triggered ICD in breast cancer cells by inducing calreticulin exposure and release of HMGB1, HSP70/90, and ATP. Mechanistically, oleandrin induced ER stress-associated, caspase-independent ICD mainly through the PERK/elF2 alpha/ATF4/CHOP pathway, suggesting its potential in combination with immune checkpoint inhibitors to improve immunotherapy efficacy.
CELL DEATH & DISEASE
(2021)
Review
Immunology
Zarema Albakova et al.
Summary: Immunotherapy has revolutionized oncology research by utilizing the host immune system for tumor destruction, with a focus on lymphoma. However, challenges such as low efficacy and on-target/off-tumor toxicity remain a major concern. Heat shock proteins, known for modulating immune responses and inhibiting apoptosis, may play a crucial role in enhancing anti-tumor responses in lymphoma patients undergoing immunotherapy.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Oncology
Diwakar Bastihalli Tukaramrao et al.
Summary: This study reports a novel compound, TPH104, that induces a unique, non-apoptotic cell death in triple-negative breast cancer (TNBC) cells by activating dendritic cells (DCs). TPH104 enhances the tumor immunogenic microenvironment to increase the efficacy of conventional chemotherapy for TNBC.
Review
Oncology
Ann Hanna et al.
Summary: Immunotherapy has revolutionized cancer treatment by targeting the immune system, yet resistance to immune checkpoint blockade poses challenges in breast cancer treatment. Heterogeneous responses to ICB in different tumors highlight the need for further research in understanding and overcoming resistance mechanisms in breast cancer to improve patient outcomes.
BREAST CANCER RESEARCH AND TREATMENT
(2021)
Review
Oncology
Carlo Ganini et al.
Summary: Advancements in sequencing technologies have enabled more accurate and comprehensive cancer sequencing projects, such as deep sequencing of entire genomes, bypassing the high costs of whole-genome sequencing. Large-scale WGS applications on databases have allowed scientists to analyze molecular features, large structural variations, and noncoding regions of the genome globally for the first time. Thorough deciphering of the vast amount of data is needed, with the emergence of machine-learning approaches expected to lead to the development of personalized approaches for cancer medicine.
MOLECULAR ONCOLOGY
(2021)
Article
Immunology
Dongqiang Zeng et al.
Summary: Recent advances in next-generation sequencing technologies have led to a rapid accumulation of publicly available multi-omics datasets. The development of IOBR as a computational tool aims to comprehensively interpret multi-omics data and facilitate immuno-oncology exploration for precision immunotherapy.
FRONTIERS IN IMMUNOLOGY
(2021)
Review
Oncology
Angela-Patricia Hernandez et al.
Summary: The concept of cancer as a single cell mass that replicates unlimitedly in isolation has been dissolved with the inclusion of immune evasion as a hallmark. Tumor microenvironment (TME) plays a crucial role in drug resistance, impacting the success of treatment. Immunogenic cell death (ICD) elicited by cancer therapy reshapes the tumor immune microenvironment, initiating a long-term adaptative immune response.
Article
Cell Biology
Haizhou Liu et al.
Summary: The study demonstrated the association of pre-treatment plasma HSP90AA1 with the risk of breast cancer onset and metastasis, showing that combining with other markers could conveniently predict patients' risk.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Article
Oncology
Claudia Tulotta et al.
Summary: Breast cancer bone metastasis is currently incurable, with IL-1B signaling playing a key role in its development. IL-1B has different effects on primary tumors and bone metastases. Targeting IL-1B signaling may provide a useful therapeutic approach to inhibiting bone metastasis and improving efficacy of current treatments for breast cancer patients.
Review
Biochemistry & Molecular Biology
Somayah Albaradei et al.
Summary: Metastasis, the primary cause of cancer-related deaths, has been the focus of research utilizing technologies like high-throughput sequencing to unravel cellular processes. Machine learning and deep learning methods have been used to predict metastasis onset, enhancing diagnostic and disease treatment outcomes.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL
(2021)
Review
Oncology
Samuel T. Workenhe et al.
Summary: The immune system recognizes tumor cells and initiates a specific T cell response, but tumors have developed mechanisms to evade immune surveillance by suppressing immunogenic cell death.
Article
Oncology
Lihong Wang-Bishop et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2020)
Review
Oncology
Lorenzo Galluzzi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2020)
Article
Biotechnology & Applied Microbiology
Tong Lin et al.
BIOMED RESEARCH INTERNATIONAL
(2020)
Review
Biochemistry & Molecular Biology
Lizhe Sun et al.
Article
Biochemical Research Methods
Wei Wang et al.
Article
Oncology
Yi Li et al.
Review
Oncology
Asma Ahmed et al.
MOLECULAR ONCOLOGY
(2020)
Review
Oncology
Daniela Bruni et al.
NATURE REVIEWS CANCER
(2020)
Article
Cell Biology
Lin Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
(2019)
Review
Pharmacology & Pharmacy
Jianming Wu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES
(2017)
Article
Oncology
Maryse Dagenais et al.
Article
Oncology
Abhishek D. Garg et al.
Article
Biotechnology & Applied Microbiology
Bo Li et al.
Article
Biochemical Research Methods
Aaron M. Newman et al.
Article
Oncology
Oliver J. Stoetzer et al.
Article
Multidisciplinary Sciences
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS
(2013)
Article
Biochemical Research Methods
Jui-Hung Hung et al.
BRIEFINGS IN BIOINFORMATICS
(2012)
Article
Biochemical Research Methods
Matthew D. Wilkerson et al.
Article
Biochemistry & Molecular Biology
Francois Ghiringhelli et al.
